Copyright
©2012 Baishideng Publishing Group Co.
World J Cardiol. May 26, 2012; 4(5): 135-147
Published online May 26, 2012. doi: 10.4330/wjc.v4.i5.135
Published online May 26, 2012. doi: 10.4330/wjc.v4.i5.135
Table 1 Classification of blood pressure for adults according to JNC-7
Classification | SBP (mmHg) | DBP (mmHg) |
Normal | ≤ 120 | And ≤ 80 |
Prehypertension | 120-139 | Or 80-89 |
Stage 1 hypertension | 140-159 | Or 90-99 |
Stage 2 hypertension | ≥ 160 | Or ≥ 100 |
Table 2 Classification of blood pressure for adults according to ESH/ESC 2007
Classification | SBP (mmHg) | DBP (mmHg) |
Οptimal | ≤ 120 | And ≤ 80 |
Normal | 120-129 | 80-84 |
High normal | 130-139 | 85-89 |
Hypertension | ||
Grade 1 (mild) | 140-159 | 90-99 |
Grade 2 (moderate) | 160-179 | 100-109 |
Grade 3 (severe) | ≥ 180 | ≥ 100 |
Isolated systolic hypertension | ≥ 140 | ≤ 90 |
Table 3 Causes of secondary hypertension
Hyperaldosteronism |
Cushing syndrome |
Coarctation of the aorta |
Renovascular stenosis |
Endocrine disorders (thyroid, parathyroid abnormalities) |
Obstructive sleep apnea |
Drugs (nonsteroidal antiinflammatory drugs, alcohol, estrogen) |
Chronic kidney disease |
Pheochromocytoma |
Table 4 Causes of resistant hypertension
False positive or pseudoresistance |
Incorrect technique in measuring blood pressure |
Pseudohypertension |
Lack of adherence to life style modifications |
Lack of patient adherence to antihypertensive therapy |
Suboptimal therapy |
True resistant hypertension |
Sleep apnea |
Hypertension related to secondary etiology |
Table 5 Therapeutic strategies
Non-pharmacological strategy |
Weight reduction |
Dietary sodium reduction |
Physical activity |
Moderate alcohol consumption |
Dash diet |
Pharmacological strategy |
Main Pharmacological agents |
Thiazide diuretic: inhibiting reabsorption of sodium (Na+) and chloride (Cl-) ions from the distal convoluted tubules in the kidneys →→↓ BP, ↓ stroke, ↓ CV mortality |
ACEIs: block the conversion of angiotensin I to angiotensin II →→↓ SVR, ↓ BP, ↓ mortality in patients with MI and left ventricular dysfunction, ↓ progression of diabetic renal disease |
ARBs: direct blockage of angiotensin II receptors →→ vasodilation (↓SVR), ↓ secretion of vasopressin, ↓ aldosterone, ↓ BP, ↓ stroke. Generally, in patients who cannot tolerate ACEs |
Calcium antagonists: disrupts the movement of calcium through calcium channels in cardiac muscle and peripheral arteries →→ vasodilation (↓ SVR), ↓ BP, ↓ CV complications in elderly patients with ISH |
β blockers: ↓ heart rate, ↓ cardiac contractility, ↓ cardiac output, inhibit renin release, ↑ nitric oxide, ↓ vasomotor tone →→↓ BP |
Other agents: direct renin inhibitors, aldosterone receptor antagonists, centrally acting agents, direct vasodilators, α-adrenergic blocking agents |
Combination therapy |
ACEIs or ARBs/Diuretic |
ACEIs or ARBs/Calcium antagonist (especially in patients with high CV risk) |
- Citation: Lionakis N, Mendrinos D, Sanidas E, Favatas G, Georgopoulou M. Hypertension in the elderly. World J Cardiol 2012; 4(5): 135-147
- URL: https://www.wjgnet.com/1949-8462/full/v4/i5/135.htm
- DOI: https://dx.doi.org/10.4330/wjc.v4.i5.135